...
首页> 外文期刊>Clinical and Translational Oncology >Molecular biology of cervical cancer
【24h】

Molecular biology of cervical cancer

机译:宫颈癌的分子生物学

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cervical cancer is a virus-induced disease that is caused by the integration of high-risk infecting human papillomaviruses (HPV) in the host genome. For this reason, the carcinogenesis process of cervical cancer is associated to the expression of the viral oncogenic proteins E6 and E7. These proteins are capable of inactivating p53 and pRb, which induces a continuous cell proliferation with the increasing risk of accumulation of DNA damage that eventually leads to cancer. Moreover, cervical cancer can be prevented by prophylactic HPV vaccines; their molecular characteristics and mechanism of action are reviewed. Ultimately, new molecular targets for cervical cancer like proteasome, the EGFR family and IGF family are exposed.
机译:宫颈癌是由病毒引起的疾病,是由高风险感染人类乳头瘤病毒(HPV)整合到宿主基因组中引起的。因此,宫颈癌的致癌过程与病毒致癌蛋白E6和E7的表达有关。这些蛋白质能够使p53和pRb失活,从而诱导连续的细胞增殖,并增加了最终导致癌症的DNA损伤累积风险。此外,预防性HPV疫苗可以预防子宫颈癌。综述了它们的分子特性和作用机理。最终,暴露了宫颈癌的新分子靶标,如蛋白酶体,EGFR家族和IGF家族。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号